Evaluating an AI-assisted triage workflow for retinal diseases.

Authors

Doohyun Park, Richul Oh, Jihyeon Baek, Kunho Bae

Published in

PLOS digital health. Volume 5. Issue 9. Pages e0001700. Epub Sep 15, 2026.

Abstract

The clinical value of artificial intelligence (AI) in fundus photography depends on workflow efficiency as well as diagnostic performance. We evaluated an AI-assisted negative-screening workflow for diabetic retinopathy (DR), retinal vein occlusion (RVO), and age-related macular degeneration (AMD) using 6,904 color fundus photographs independently graded by three retina specialists. In this workflow, AI-negative images were classified as negative without ophthalmologist review, whereas AI-positive images were referred for human interpretation. For each reader-disease pair, the reference standard was agreement between the other two readers; discordant cases were excluded (DR, 1.2%-2.3%; RVO, 0.3%-0.6%; AMD, 6.1%-11.6%). The workflow reduced direct ophthalmologist review to 7.3%-8.0% of images for DR, 11.7%-11.9% for RVO, and 13.5%-16.8% for AMD. For DR, sensitivity decreased significantly (0.9168 to 0.8838; difference, -0.0330; 95% confidence interval [CI], -0.0495 to -0.0165; p < 0.001), whereas specificity did not change significantly (0.9961 to 0.9983; p = 0.183). For RVO, sensitivity was unchanged (0.9807) and specificity did not change significantly (0.9985 to 0.9988; p = 0.320). For AMD, sensitivity decreased significantly (0.8570 to 0.8445; difference, -0.0124; 95% CI, -0.0215 to -0.0033; p = 0.008), whereas specificity did not change significantly (0.9685 to 0.9843; p = 0.324). In an exploratory image-level analysis for at least one target disease, review decreased to 27.7%-30.1%; sensitivity changed from 0.9122 to 0.9039 (difference, -0.0083; 95% CI, -0.0131 to -0.0035; p < 0.001) and specificity from 0.9659 to 0.9804 (p = 0.334). AI-assisted negative-screening can reduce ophthalmologist workload across multiple retinal diseases, but with disease-specific safety trade-offs: because AI-negative images are not reviewed, reduced sensitivity for DR and AMD means a small proportion of true-positive cases would go undetected, potentially delaying diagnosis and treatment for sight-threatening disease. These results support disease-specific implementation strategies that balance workload reduction against missed positive cases.

PMID:
42743257
Bibliographic data and abstract were imported from PubMed on 16 Sep 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.